Viking Therapeutics, Inc.
A biopharmaceutical company focused on developing novel therapeutics for metabolic and endocrine disorders. The company is conducting clinical trials for non-alcoholic steatohepatitis, obesity and metabolic disorders, as well as developing treatments for high LDL cholesterol, type 2 diabetes, and X-linked adrenoleukodystrophy. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 27 |
Founded | 2012 |
Financials | |
|---|---|
Market Capitalization | 6.31B |
Revenue | |
Operating Income | -114.36M |
Operating Margin | |
Net Income | -93.72M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4846 / 5373 |
Sector : Healthcare | 912 / 1144 |
Industry : Biotechnology | 472 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 1115 / 5565 |
Sector : Healthcare | 124 / 1182 |
Industry : Biotechnology | 29 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4713 / 5436 |
Sector : Healthcare | 879 / 1164 |
Industry : Biotechnology | 452 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4701 / 5330 |
Sector : Healthcare | 913 / 1174 |
Industry : Biotechnology | 457 / 667 |